- Advanced search
- Immuno Portal
- Malaria Portal
Synonyms: D2E7  | Humira®
adalimumab is an approved drug (FDA (2002), EMA (2003))
Compound class: Antibody
Comment: Adalimumab is an anti-TNFα monoclonal antibody with immunosuppresive activity . It was the first fully human monoclonal antibody drug approved by the FDA.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
X-ray structures of the apo and TNFα-bound Fab fragment of adalimumab have been deposited to the RCSB Protein Data Bank (IDs 4NYL and 3WD5 respectively).
View more information in the IUPHAR Pharmacology Education Project: adalimumab
|Approved drug?||Yes (FDA (2002), EMA (2003))|
|WHO Essential Medicine||WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version.
Click to view more information about the WHO Model Lists of Essential Medicines.
|International Nonproprietary Names|
|D2E7  | Humira®|
|GtoPdb PubChem SID||178101561|
|Search PubMed clinical trials||adalimumab|
|Search PubMed titles||adalimumab|
|Search PubMed titles/abstracts||adalimumab|